Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating larazotide acetate for relief of celiac disease symptoms was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• larazotide acetate (larazotide acetate)

Snippet

Sponsor: 9 Meters Biopharma, Inc. | Conditions: Celiac Disease | Phase 3 | Status: TERMINATED